XNAS: FATE
Fate Therapeutics Inc Live Stock Price Today, Share Analysis and Chart
about
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. The company is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline ...
Read More
2.02
-0.12
(-5.61%)
2.1M
XNAS Volume
XNAS 14 May, 2026 12:11 PM (EDT)
Board Meeting
The latest board meeting for Fate Therapeutics Inc took place on 13 May 2026, for the purpose of Fate Therapeutics Inc First Quarter Earnings Results for 2026
See details
Not Eligible
Expensive Valuation
Technically Bullish
Fate Therapeutics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..